Insider trades
Greg Zante, CFO of Viking Therapeutics VKTX, has filed 0 purchases and 29 sales on the open market. Over the past 12 months that comes to a net sale of $2.1M. The latest trade was on 01/05.
Greg Zante
CFO
- Company
- Viking Therapeutics VKTX
- First filing
- 23/01/04
- Trades
- 93 trades
- Buys / sales
- 0 / 29
- 12-month net buying
- −$2.1M
- Last trade
- 01/05
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
VKTX | Open-market sale | 01/05 | 01/05 | 57,661 sh4 trades | $32.90avg. | $1,897,129.3 | −23.3% |
| Open-market sale | 25/10/28 | 25/10/28 | 6,185 sh | $35.00 | $216,475 | −3.4% | |
| Open-market sale | 25/07/03 | 25/07/03 | 4,266 sh | $27.76 | $118,424.16 | −2.5% | |
VKTX | Open-market sale | 25/01/06 | 25/01/06 | 50,309 sh2 trades | $42.75avg. | $2,150,652.21 | −23.3% |
VKTX | Open-market sale10b5-1 plan | 24/10/28 | 24/10/28 | 131,687 sh8 trades | $76.62avg. | $10,089,306.42 | −46.9% |
VKTX | Open-market sale | 24/07/30 | 24/07/31 | 16,136 sh3 trades | $57.15avg. | $922,212.06 | −7.9% |
VKTX | Open-market sale10b5-1 plan | 24/05/03 | 24/05/03 | 66,756 sh4 trades | $74.69avg. | $4,985,851.2 | −27.6% |
| Open-market sale | 24/01/04 | 24/01/04 | 15,000 sh | $17.90 | $268,500 | −7.7% | |
| Open-market sale | 23/04/17 | 23/04/18 | 7,500 sh | $20.00 | $150,000 | −4.8% | |
VKTX | Open-market sale | 23/04/11–23/04/12 | 23/04/13 | 97,839 sh2 trades | $18.00avg. | $1,761,102 | −39.6% |
VKTX | Open-market sale | 23/03/30–23/04/03 | 23/04/03 | 161,940 sh2 trades | $17.19avg. | $2,783,891 | −52.3% |